+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Pain Management Market by Drug Class, Route Of Administration, Distribution Channel, End User, Application - Global Forecast to 2030- Product Image
Cancer Pain Management Market by Drug Class, Route Of Administration, Distribution Channel, End User, Application - Global Forecast to 2030- Product Image
Sale

Cancer Pain Management Market by Drug Class, Route Of Administration, Distribution Channel, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924846
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cancer pain management market is experiencing pivotal shifts in therapy innovation, patient-centric care models, and supply chain dynamics. As treatment paradigms evolve, industry stakeholders must harness data-driven intelligence to navigate regulatory, technological, and regional complexities for sustained growth and improved patient outcomes.

Market Snapshot: Cancer Pain Management Market Trends & Growth

The Cancer Pain Management Market grew from USD 7.86 billion in 2024 to USD 8.35 billion in 2025. It is expected to continue growing at a CAGR of 6.13%, reaching USD 11.24 billion by 2030. This expansion reflects rising adoption of novel pain management therapies, advanced drug delivery methods, and the ongoing refinement of reimbursement and patient access models across diverse healthcare systems.

Scope & Segmentation of the Cancer Pain Management Market

This comprehensive report offers actionable intelligence across multiple segmentation layers and technological domains, giving decision-makers a 360-degree understanding of the market’s structure and potential.

  • Drug Classes: Covers adjuvant analgesics such as anticonvulsants, antidepressants, corticosteroids, local anesthetics, NSAIDs, as well as natural, semi-synthetic, and synthetic opioids.
  • Routes of Administration: Includes oral (capsules, solutions, tablets), parenteral (intramuscular, intravenous, subcutaneous), sublingual (films, lozenges), and transdermal options.
  • Distribution Channels: Encompasses hospital, online, and retail pharmacy networks supporting both inpatient and outpatient therapeutic workflows.
  • End Users: Assesses utilization within cancer institutes, home care settings, and hospitals, each with distinct procurement and delivery needs.
  • Applications: Segmentation by pain type—bone metastasis, neuropathic, and visceral pain—offers nuanced insights into targeted protocol development.
  • Regions Analyzed: In-depth coverage of the Americas, Europe, Middle East & Africa, and Asia-Pacific, with country- and state-level granularity for tailored strategic approaches.
  • Technological Advances: Profile of next-generation analgesics, novel drug delivery systems, and the rise of digital health integration for remote monitoring and adherence support.

Key Takeaways for Senior Decision-Makers

  • Precision medicine is driving a gradual shift toward individualized analgesic regimens, enhancing patient experience and supporting differentiated value propositions.
  • Non-invasive drug delivery is gaining traction, as both clinicians and patients seek modalities that reduce systemic side effects and improve adherence.
  • Regulatory engagement and streamlined approval processes have broadened permissible indications for emerging pain therapies, intensifying competition and innovation.
  • Stakeholders are responding to evolving payer expectations by adopting value-based reimbursement models and prioritizing outcome-driven evidence in formulary negotiations.
  • Robust regional investments—particularly in North America, Asia-Pacific, and select Latin American markets—are expanding access, shaping competitive dynamics, and driving operational agility.
  • Growth opportunities abound for companies leveraging advanced manufacturing technologies and digital infrastructure to achieve cost efficiencies despite external pressures.

Tariff Impact: Navigating the 2025 Trade Environment

The imposition of cumulative US tariffs in 2025 has increased costs for both active pharmaceutical ingredients and finished cancer pain therapies. These changes prompted many manufacturers to adjust sourcing strategies, including diversifying supplier bases and strengthening domestic procurement. New pricing pressures have influenced payer negotiations and encouraged adoption of value-based contracting, which aligns reimbursement more closely with patient outcomes. Investments in local manufacturing and supply chain digitization have enabled agile responses to these challenges and helped offset incremental cost risks.

Methodology & Data Sources

Insights draw from primary interviews with oncologists, pharmacists, payers, and advocacy groups, plus rigorous analysis of regulatory filings, clinical trial data, and peer-reviewed studies. Top-down and bottom-up modeling approaches, combined with qualitative expert validation, ensure robust coverage of market structure, segmentation, and emerging trends.

Why This Report Matters for Leadership Planning

  • Enables strategic prioritization in a landscape of evolving therapies, regulatory shifts, and diversified care settings.
  • Identifies actionable opportunities linked to technology adoption, process optimization, and successful market access strategies across regions.
  • Informs investment decisions by clarifying the interplay between tariff policies, manufacturing innovation, and long-term revenue streams.

Conclusion

The future of cancer pain management will be shaped by informed decision-making, proactive adaptation to market forces, and continued technological progress. Leaders who embrace integrated, evidence-based strategies are well positioned to drive sustained impact in this rapidly evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cancer Pain Management Market, by Drug Class
8.1. Introduction
8.2. Adjuvant Analgesics
8.2.1. Anticonvulsants
8.2.2. Antidepressants
8.2.3. Corticosteroids
8.3. Local Anesthetics
8.4. Nsaids
8.5. Opioids
8.5.1. Natural
8.5.2. Semi-Synthetic
8.5.3. Synthetic
9. Cancer Pain Management Market, by Route Of Administration
9.1. Introduction
9.2. Oral
9.2.1. Capsules
9.2.2. Solutions
9.2.3. Tablets
9.3. Parenteral
9.3.1. Intramuscular
9.3.2. Intravenous
9.3.3. Subcutaneous
9.4. Sublingual
9.4.1. Films
9.4.2. Lozenges
9.5. Transdermal
10. Cancer Pain Management Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Cancer Pain Management Market, by End User
11.1. Introduction
11.2. Cancer Institutes
11.3. Home Care
11.4. Hospitals
12. Cancer Pain Management Market, by Application
12.1. Introduction
12.2. Bone Metastasis Pain
12.3. Neuropathic Pain
12.4. Visceral Pain
13. Americas Cancer Pain Management Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cancer Pain Management Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cancer Pain Management Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Johnson & Johnson
16.3.3. Pfizer Inc.
16.3.4. Viatris Inc.
16.3.5. Endo International plc
16.3.6. Hikma Pharmaceuticals PLC
16.3.7. Grünenthal GmbH
16.3.8. Mallinckrodt Pharmaceuticals
16.3.9. Purdue Pharma L.P.
16.3.10. Mayne Pharma Group Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CANCER PAIN MANAGEMENT MARKET MULTI-CURRENCY
FIGURE 2. CANCER PAIN MANAGEMENT MARKET MULTI-LANGUAGE
FIGURE 3. CANCER PAIN MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CANCER PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CANCER PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CANCER PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SEMI-SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY LOZENGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY CANCER INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY BONE METASTASIS PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CANCER PAIN MANAGEMENT MARKET SIZE, BY VISCERAL PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CANCER PAIN MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 70. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 71. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 72. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 74. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 75. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 76. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. CANADA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 131. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 133. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 135. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 136. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 137. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. GERMANY CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 141. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 143. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 161. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 162. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 163. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 165. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 166. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 167. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. ITALY CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 171. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 173. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 175. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 176. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 177. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. SPAIN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 211. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 212. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 213. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 215. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 216. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 217. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. DENMARK CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 231. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 232. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 233. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 235. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 236. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 237. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. QATAR CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 241. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 242. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 243. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 244. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 245. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 246. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 247. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. FINLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 271. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 272. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 273. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 274. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 275. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 276. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 277. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. EGYPT CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 281. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 282. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 283. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 284. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 285. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 286. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 287. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. TURKEY CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 301. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 302. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 303. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 304. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 305. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 306. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 307. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. NORWAY CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 311. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 312. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 313. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 315. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 316. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 317. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. POLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND CANCER PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ADJUVANT ANALGESICS, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC CANCER PAIN MANAGEMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cancer Pain Management market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson
  • Pfizer Inc.
  • Viatris Inc.
  • Endo International plc
  • Hikma Pharmaceuticals PLC
  • Grünenthal GmbH
  • Mallinckrodt Pharmaceuticals
  • Purdue Pharma L.P.
  • Mayne Pharma Group Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.24 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pain Management Therapeutics Market by Drug Class, Route Of Administration, Indication, Distribution Channel, End User - Global Forecast to 2030 - Product Image

Pain Management Therapeutics Market by Drug Class, Route Of Administration, Indication, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Cancer Pain Management - Global Strategic Business Report - Product Image

Cancer Pain Management - Global Strategic Business Report

  • Report
  • 588 Pages
  • Global
From
Pain Management Devices Market by Device Type, Application, Distribution Channel, End User, Mode of Purchase - Global Forecast to 2030 - Product Image

Pain Management Devices Market by Device Type, Application, Distribution Channel, End User, Mode of Purchase - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Pain Management Devices Market Size, Share & Trends Analysis Report By Application (Neuropathic, Cancer), By Product (Electrical Stimulators, Radiofrequency Ablation, Analgesic Infusion Pump), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Pain Management Devices Market Size, Share & Trends Analysis Report By Application (Neuropathic, Cancer), By Product (Electrical Stimulators, Radiofrequency Ablation, Analgesic Infusion Pump), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 140 Pages
  • Global
From
Post Operative Pain Management Global Market Report 2025 - Product Image

Post Operative Pain Management Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Cancer Pain Management Market

The Cancer Pain Management market within the context of Palliative Care is focused on providing relief from the physical and psychological symptoms of cancer. This includes managing pain, fatigue, nausea, depression, anxiety, and other symptoms. Pain management strategies may include medications, physical therapy, psychological counseling, and other treatments. Palliative care also includes providing emotional and spiritual support to patients and their families. Companies in the Cancer Pain Management market include pharmaceutical companies, medical device manufacturers, and healthcare providers. Examples include Pfizer, Merck, Johnson & Johnson, Novartis, and AbbVie. Additionally, there are a number of specialized companies that focus on providing palliative care services, such as Hospice Care, Inc., and Comfort Care Hospice. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.